X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3274) 3274
Book Review (851) 851
Publication (326) 326
Book Chapter (12) 12
Conference Proceeding (10) 10
Dissertation (4) 4
Magazine Article (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
sunitinib (2945) 2945
index medicus (2794) 2794
humans (2581) 2581
oncology (1915) 1915
female (1380) 1380
male (1380) 1380
cancer (1318) 1318
carcinoma, renal cell - drug therapy (1189) 1189
middle aged (1175) 1175
antineoplastic agents - therapeutic use (1161) 1161
kidney neoplasms - drug therapy (1149) 1149
aged (1059) 1059
sorafenib (1048) 1048
indoles - therapeutic use (889) 889
pyrroles - therapeutic use (879) 879
treatment outcome (819) 819
interferon-alpha (796) 796
adult (788) 788
metastasis (780) 780
kidney neoplasms - pathology (759) 759
renal cell carcinoma (746) 746
care and treatment (678) 678
carcinoma, renal cell (668) 668
tyrosine kinase inhibitor (585) 585
survival (567) 567
bevacizumab (555) 555
carcinoma, renal cell - pathology (519) 519
endothelial growth-factor (498) 498
protein kinase inhibitors - therapeutic use (494) 494
urology & nephrology (479) 479
pharmacology & pharmacy (475) 475
disease-free survival (471) 471
aged, 80 and over (455) 455
renal-cell carcinoma (452) 452
antineoplastic agents (447) 447
therapy (447) 447
angiogenesis inhibitors - therapeutic use (437) 437
animals (433) 433
antimitotic agents (433) 433
vascular endothelial growth factor (431) 431
antineoplastic agents - adverse effects (427) 427
retrospective studies (421) 421
tumors (418) 418
angiogenesis (417) 417
everolimus (417) 417
efficacy (410) 410
prognosis (409) 409
niacinamide - analogs & derivatives (398) 398
targeted therapy (395) 395
analysis (393) 393
medicine & public health (393) 393
chemotherapy (378) 378
indoles - adverse effects (375) 375
carcinoma, renal cell - secondary (373) 373
pyrroles - adverse effects (370) 370
neoplasm metastasis (364) 364
drug therapy (363) 363
tyrosine (340) 340
research (336) 336
antineoplastic combined chemotherapy protocols - therapeutic use (334) 334
indoles - administration & dosage (333) 333
trial (328) 328
pyrroles - administration & dosage (327) 327
double-blind (310) 310
hematology, oncology and palliative medicine (308) 308
phase-iii trial (301) 301
kidney cancer (300) 300
carcinoma, renal cell - mortality (289) 289
carcinoma (285) 285
pazopanib (283) 283
kidney neoplasms - mortality (279) 279
phase-ii (275) 275
urology (273) 273
tyrosine kinase inhibitors (246) 246
safety (238) 238
antineoplastic agents - administration & dosage (229) 229
antineoplastic agents - pharmacology (229) 229
antitumor-activity (229) 229
vegf (229) 229
indoles - pharmacology (227) 227
pyrroles - pharmacology (227) 227
expression (225) 225
imatinib (225) 225
health aspects (220) 220
immunotherapy (217) 217
clinical trials (213) 213
temsirolimus (213) 213
protein kinase inhibitors - adverse effects (209) 209
pyrimidines - therapeutic use (209) 209
development and progression (205) 205
imatinib mesylate (205) 205
mice (205) 205
molecular targeted therapy (201) 201
patients (201) 201
angiogenesis inhibitors (199) 199
pyridines - therapeutic use (198) 198
hypertension (197) 197
neoplasms - drug therapy (197) 197
phenylurea compounds (194) 194
metastatic renal cell carcinoma (193) 193
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3210) 3210
German (27) 27
French (24) 24
Spanish (13) 13
Russian (4) 4
Japanese (3) 3
Catalan (1) 1
Chinese (1) 1
Hungarian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2012, Volume 30, Issue 5, pp. 482 - 487
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9807, pp. 1931 - 1939
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10064, pp. 56 - 66
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2015, Volume 33, Issue 2, pp. 172 - 179
Purpose This open-label phase III trial evaluated efficacy and tolerability of linifanib versus sorafenib in patients with advanced hepatocellular carcinoma... 
ANGIOGENESIS | ONCOLOGY | PATHWAY | SUNITINIB | ABT-869 | RISK | BRIVANIB | INHIBITOR | CANCER | EXPRESSION | ENDOTHELIAL GROWTH-FACTOR | Niacinamide - analogs & derivatives | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Hand-Foot Syndrome - etiology | Indazoles - administration & dosage | Protein Kinase Inhibitors - adverse effects | Liver Neoplasms - etiology | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Hypertension - chemically induced | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Liver Neoplasms - pathology | Carcinoma, Hepatocellular - etiology | Odds Ratio | Drug Administration Schedule | Risk Factors | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Niacinamide - adverse effects | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Treatment Outcome | Niacinamide - administration & dosage | Protein Kinase Inhibitors - administration & dosage | Phenylurea Compounds - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Sorafenib | Carcinoma, Hepatocellular - pathology | Aged | Indazoles - adverse effects | Indazoles - therapeutic use | Index Medicus | Bone3 | ORIGINAL REPORTS | Bios3
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 13, pp. 1287 - 1294
Journal Article
Journal of Oral and Maxillofacial Surgery, ISSN 0278-2391, 2013, Volume 71, Issue 9, pp. 1532 - 1540
Purpose To investigate the efficacy and safety of zoledronic acid (ZA) combined with targeted therapy (TT). Materials and Methods A retrospective study was... 
Surgery | SURVIVAL | PROSTATE | ADHESION | BISPHOSPHONATES | CANCER-PATIENTS | NECROSIS | DENTISTRY, ORAL SURGERY & MEDICINE | SKELETAL-RELATED EVENTS | SUNITINIB | BREAST | PROGRESSION | Niacinamide - analogs & derivatives | Follow-Up Studies | Humans | Middle Aged | Interleukin-2 - therapeutic use | Bone Neoplasms - secondary | Male | Antineoplastic Agents - therapeutic use | Bevacizumab | Angiogenesis Inhibitors - therapeutic use | Diphosphonates - therapeutic use | Adult | Female | Retrospective Studies | Bone Neoplasms - drug therapy | Imidazoles - therapeutic use | Carcinoma, Renal Cell - drug therapy | Pyrroles - therapeutic use | Diphosphonates - adverse effects | Everolimus | Molecular Targeted Therapy - methods | Radiography, Panoramic | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Bone Density Conservation Agents - adverse effects | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Fractures, Spontaneous - etiology | Survival Rate | Spinal Cord Compression - etiology | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Carcinoma, Renal Cell - secondary | Indoles - therapeutic use | Kidney Neoplasms - pathology | Aged | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Cohort Studies | Care and treatment | Trade and professional associations | Metastasis | Index Medicus | Abridged Index Medicus | Dentistry
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 3, pp. 286 - 296
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 19, pp. 1814 - 1823
Journal Article
Journal of Urology, The, ISSN 0022-5347, 2008, Volume 180, Issue 3, pp. 860 - 866
Journal Article
Journal of Urology, The, ISSN 0022-5347, 2011, Volume 185, Issue 1, pp. 60 - 66
Journal Article